2241 Outcome of peptide receptor radionuclide therapy with 177Luoctreotate in advanced neuroendocrine tumours (NET): South Australian sub study of the SIGNETURe Registry. (September 2015) - Patel, D.; Lawrie, J.; Cehic, G.; Kitchener, M.; Unger, S.; Singhal, N.; Karapetis, C.; Michael, M.; Kotasek, D.; Chua, Y.J.; Price, T.